Business

Abivax’s Obefazimod Advances in Ulcerative Colitis Treatment Paris, France – 12 January 2026 – Abivax SA has made significant strides in the development of obefazimod, its first-in-class oral miR-124 enhancer, for the treatment of moderately to severely active ulcerative colitis (UC). Following positive Phase 3 induction trial results announced in July 2025, the company is […]

Lidl to Halt Broadcast TV Advertising in France Amid Regulatory Concerns Paris, 8 January 2026 – German discount supermarket chain Lidl has announced it will stop investing in broadcast television advertisements in France, citing high regulatory risks following a costly court defeat last year. The move affects one of France’s top advertisers and raises questions